CVS Caremark Makes Changes in Diabetes Coverage for 2025
2024年11月25日 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that …
UnitedHealthcare Adds Deductibles to Medicare Part D for 2025
2024年10月3日 · UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.
Top 5 Podcast Episodes of 2024
2025年1月1日 · Loren McCaghy of Accenture Suggests Digital Engagement, Ease of Use as Key Drivers in Healthcare Provider and Payer Turnover In this latest episode of Tuning In to the C …
Unlocking Better Health: Why Health Literacy Needs a Digital …
2024年10月30日 · The challenges are manifold, explains Alison Lyne, senior director of growth at Ushur: “Medical language is often complex and filled with jargon that can confuse even the …
Aetna Updates MA and Drug Programs for Medicare in 2025
2024年10月1日 · In 2025, Aetna, the health insurance company of CVS Health, has added several new programs to Medicare for 2025. Aetna will launch new Chronic Condition Special …
Prime Therapeutics Announces Rebranding, New Look
2024年9月16日 · Prime, headquartered in Eagan, Minnesota, is one of six largest pharmacy benefit managers (PBMs) in the country, an industry that has come under increasing criticism …
MHE November 2024 - managedhealthcareexecutive.com
2024年11月5日 · Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven …
Furthering Managed Care Through Advances in IgA Nephropathy …
2024年9月24日 · Introduction. Immunoglobulin A nephropathy (IgAN), also known as Berger disease, is an autoimmune condition and the most common type of primary glomerulonephritis …
Drug Channels Acquired by HMP Global - Managed Healthcare …
2024年1月4日 · HMP Global, a healthcare education company, will acquire Drug Channels Institute. Founded in 2006 by Adam J. Fein, Ph.D., Drug Channels is a market intelligence …
Analysis Finds Winrevair Effective Across Cardiac Index Groups
2024年12月17日 · A new pooled analysis of two Winrevair (sotatercept) trials suggests the first-in-class pulmonary arterial hypertension (PAH) therapy works regardless of the patient’s baseline …